NIKE INC -CL B
NKENYSE🏆 #272 by market capEarnings Dec 17 · PostUS Equity
——
Quote unavailableTrack NKE
Get earnings, price moves & breaking news on Telegram
24h—
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$48.92B
Mid Cap
📈Revenue Growth (YoY)
-1.2%
Declining
📊Gross Margin
43.1%
Healthy
💵FCF Margin
4.8%
Moderate
⚖️P/S Ratio
1.1x
Cheap
Otter Score
64
Fair
NIKE INC -CL B
NKEAnalyst Ratings
Total
29
Raised
1
Lowered
22
Avg PT
$37.96
H / L
$75 / $19
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Jefferies Nike | Lowered | Buy | 2026-07-01 | $75.00 | — |
Bernstein Nike | Lowered | Outperform | 2026-07-01 | $72.00 | — |
Oppenheimer Nike | Lowered | Outperform | 2026-09-23 | $52.00 | — |
Freedom Broker Nike | Lowered | Sell → Buy | 2026-10-02 | $51.00 | — |
BTIG Nike | Reiterated | Buy | 2026-11-12 | $50.00 | — |
Guggenheim Nike | Reiterated | Buy | 2026-10-22 | $50.00 | — |
Barclays Nike | Lowered | Overweight | 2026-11-18 | $42.00 | — |
RBC Capital Nike | Lowered | Sector Perform | 2026-11-06 | $39.00 | — |
Deutsche Bank Nike | Lowered | Hold | 2026-09-28 | $37.00 | — |
Baird Nike | Lowered | Neutral | 2026-10-02 | $36.00 | — |
Stifel Nike | Lowered | Hold | 2026-10-02 | $36.00 | — |
Evercore ISI Group Nike | Raised | In-Line | 2026-11-18 | $35.00 | — |
Telsey Advisory Group Nike | Lowered | Market Perform | 2026-10-02 | $35.00 | — |
UBS Nike | Lowered | Neutral | 2026-10-02 | $34.00 | — |
Cantor Fitzgerald Nike | Lowered | Neutral | 2026-11-20 | $33.00 | — |
JP Morgan Nike | Lowered | Underweight | 2026-10-02 | $33.00 | — |
Citigroup Nike | Lowered | Neutral | 2026-10-02 | $32.00 | — |
Goldman Sachs Nike | Lowered | Neutral | 2026-10-02 | $30.00 | — |
Wells Fargo Nike | Lowered | Equal-Weight | 2026-10-02 | $30.00 | — |
BMO Capital Nike | Initiated | Underperform | 2026-09-09 | $30.00 | — |
Truist Securities Nike | Downgraded | Hold → Sell | 2026-11-05 | $29.00 | — |
Wolfe Research Nike | Initiated | Underperform | 2026-10-22 | $28.00 | — |
Piper Sandler Nike | Lowered | Neutral | 2026-10-02 | $28.00 | — |
Morgan Stanley Nike | Lowered | Underweight | 2026-10-02 | $27.00 | — |
B of A Securities Nike | Lowered | Underperform | 2026-10-02 | $24.00 | — |
BNP Paribas Nike | Lowered | Underperform | 2026-10-02 | $19.00 | — |
StoneX Nike | Reiterated | Hold | 2026-10-02 | — | — |
Needham Nike | Reiterated | Hold | 2026-10-02 | — | — |
Keybanc Nike | Downgraded | Overweight → Sector Weight | 2026-06-26 | — | — |
Institution
Jefferies
Lowered · Buy · 2026-07-01
$75.00
—
Bernstein
Lowered · Outperform · 2026-07-01
$72.00
—
Oppenheimer
Lowered · Outperform · 2026-09-23
$52.00
—
Freedom Broker
Lowered · Sell → Buy · 2026-10-02
$51.00
—
BTIG
Reiterated · Buy · 2026-11-12
$50.00
—
Guggenheim
Reiterated · Buy · 2026-10-22
$50.00
—
Barclays
Lowered · Overweight · 2026-11-18
$42.00
—
RBC Capital
Lowered · Sector Perform · 2026-11-06
$39.00
—
Deutsche Bank
Lowered · Hold · 2026-09-28
$37.00
—
Baird
Lowered · Neutral · 2026-10-02
$36.00
—
Stifel
Lowered · Hold · 2026-10-02
$36.00
—
Evercore ISI Group
Raised · In-Line · 2026-11-18
$35.00
—
Telsey Advisory Group
Lowered · Market Perform · 2026-10-02
$35.00
—
UBS
Lowered · Neutral · 2026-10-02
$34.00
—
Cantor Fitzgerald
Lowered · Neutral · 2026-11-20
$33.00
—
JP Morgan
Lowered · Underweight · 2026-10-02
$33.00
—
Citigroup
Lowered · Neutral · 2026-10-02
$32.00
—
Goldman Sachs
Lowered · Neutral · 2026-10-02
$30.00
—
Wells Fargo
Lowered · Equal-Weight · 2026-10-02
$30.00
—
BMO Capital
Initiated · Underperform · 2026-09-09
$30.00
—
Truist Securities
Downgraded · Hold → Sell · 2026-11-05
$29.00
—
Wolfe Research
Initiated · Underperform · 2026-10-22
$28.00
—
Piper Sandler
Lowered · Neutral · 2026-10-02
$28.00
—
Morgan Stanley
Lowered · Underweight · 2026-10-02
$27.00
—
B of A Securities
Lowered · Underperform · 2026-10-02
$24.00
—
BNP Paribas
Lowered · Underperform · 2026-10-02
$19.00
—
StoneX
Reiterated · Hold · 2026-10-02
—
—
Needham
Reiterated · Hold · 2026-10-02
—
—
Keybanc
Downgraded · Overweight → Sector Weight · 2026-06-26
—
—
One row per institution · price target from the firm's latest published target